Literature DB >> 24385679

Synthesis of a Library of 1,5,2-Dithiazepine 1,1-Dioxides. Part 1: A One-Pot Sulfonylation/Thia-Michael Protocol.

Qin Zang1, Aihua Zhou1, Salim Javed2, Pradip K Maity1, Chris A Knudtson1, Danse Bi1, Jared J Hastings1, Fatima Z Basha3, Paul R Hanson1.   

Abstract

A novel one-pot sulfonylation/intramolecular thia-Michael protocol is reported for the synthesis of 1,5,2-dithiazepine 1,1-dioxides. Sulfonylation between cysteine ethyl ester/cysteamine and 2-chloroethanesulfonyl chloride, followed by in situ intramolecular thia-Michael addition, was achieved and afforded the titled 1,5,2-dithiazepine-1,1-dioxide scaffolds. Diversification was demonstrated for future library synthesis.

Entities:  

Year:  2012        PMID: 24385679      PMCID: PMC3873773          DOI: 10.3987/COM-12-S(N)121

Source DB:  PubMed          Journal:  Heterocycles        ISSN: 0385-5414            Impact factor:   0.831


  32 in total

1.  Organocatalytic asymmetric sulfa-michael/michael addition reactions: a strategy for the synthesis of highly substituted chromans with a quaternary stereocenter.

Authors:  Xu-Fan Wang; Qiu-Lin Hua; Ying Cheng; Xiao-Lei An; Qing-Qing Yang; Jia-Rong Chen; Wen-Jing Xiao
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-02       Impact factor: 15.336

2.  Enantioselective organocatalytic domino oxa-Michael/aldol/hemiacetalization: synthesis of polysubstituted furofuranes containing four stereocenters.

Authors:  Efraím Reyes; Garazi Talavera; Jose L Vicario; Dolores Badía; Luisa Carrillo
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

3.  A stereoselective formal synthesis of leucascandrolide A.

Authors:  Kiyoun Lee; Hyoungsu Kim; Jiyong Hong
Journal:  Org Lett       Date:  2011-04-29       Impact factor: 6.005

Review 4.  Recent developments in the field of oxa-Michael reactions.

Authors:  Carl F Nising; Stefan Bräse
Journal:  Chem Soc Rev       Date:  2011-07-28       Impact factor: 54.564

5.  Stereoselective synthesis of 2,6-cis- and 2,6-trans-piperidines through organocatalytic aza-Michael reactions: a facile synthesis of (+)-myrtine and (-)-epimyrtine.

Authors:  Yongcheng Ying; Hyoungsu Kim; Jiyong Hong
Journal:  Org Lett       Date:  2011-01-20       Impact factor: 6.005

6.  Application of a Double Aza-Michael Reaction in a 'Click, Click, Cy-Click' Strategy: From Bench to Flow.

Authors:  Qin Zang; Salim Javed; Farman Ullah; Aihua Zhou; Christopher A Knudtson; Danse Bi; Fatima Z Basha; Michael G Organ; Paul R Hanson
Journal:  Synthesis (Stuttg)       Date:  2011-09-01       Impact factor: 3.157

7.  Tandem asymmetric Michael reaction-intramolecular Michael addition. An easy entry to chiral fluorinated 1,4-dihydropyridines.

Authors:  Santos Fustero; Silvia Catalán; María Sánchez-Roselló; Antonio Simón-Fuentes; Carlos del Pozo
Journal:  Org Lett       Date:  2010-08-06       Impact factor: 6.005

8.  Efficient synthesis of multicyclic spirooxindoles via a cascade Michael/Michael/oxa-Michael reaction of curcumins and isatylidene malononitriles.

Authors:  Xiao-Gang Yin; Xin-Yun Liu; Zhi-Peng Hu; Ming Yan
Journal:  Org Biomol Chem       Date:  2012-01-09       Impact factor: 3.876

9.  Automated synthesis of a 184-member library of thiadiazepan-1,1-dioxide-4-ones.

Authors:  Erik Fenster; Toby R Long; Qin Zang; David Hill; Benjamin Neuenswander; Gerald H Lushington; Aihua Zhou; Conrad Santini; Paul R Hanson
Journal:  ACS Comb Sci       Date:  2011-02-10       Impact factor: 3.784

10.  Domino Heck-aza-Michael reactions: efficient access to 1-substituted tetrahydro-beta-carbolines.

Authors:  Daniel L Priebbenow; Luke C Henderson; Frederick M Pfeffer; Scott G Stewart
Journal:  J Org Chem       Date:  2010-03-05       Impact factor: 4.354

View more
  1 in total

1.  A summary of seven- and eight-membered ring sultam syntheses via three Michael addition reactions.

Authors:  Ben Niu; Ping Xie; Min Wang; Yanjie Wang; Wannian Zhao; Charles U Pittman; Aihua Zhou
Journal:  Mol Divers       Date:  2015-04-03       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.